RxDoctor Payments Data

David McMullen, DO

Family Medicine · Raleigh, NCNPI 1265963938

Payments from drug & device makers

$2,014in general payments, 2019–2025

Across 101 payments — averaging $19.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$355
  • AstraZeneca$231
  • AbbVie$230
  • Pfizer$166
  • Otsuka America Pharmaceutical, Inc.$165
  • Exact Sciences$163
  • plus $704 from 18 others

What the payments were for

  • Food & beverage$2,00099%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,014 in reported general payments places this provider in the 80th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$45,540
Medicare patients
103
Services billed
563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide34$53,905
EliquisApixaban20$34,648
TrulicityDulaglutide13$29,445
JardianceEmpagliflozin16$26,233
MounjaroTirzepatide15$19,493
FarxigaDapagliflozin Propanediol12$19,193
Atorvastatin Calcium409$4,325
Levothyroxine Sodium118$1,599
Omeprazole89$1,475
Lisinopril148$1,462
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide15$1,406
Metoprolol Succinate55$1,259
Losartan Potassium92$1,245
Simvastatin80$1,158
Bupropion XlBupropion Hcl30$1,086

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$355$53,90534 claims
Lilly USA, LLCTrulicity, Mounjaro$121$48,93828 claims
PfizerEliquis$166$34,64820 claims
Boehringer IngelheimJardiance$52$26,23316 claims
AstraZenecaFarxiga$231$19,19312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →